| Outcome Measures: |
Primary: Percent Change from Baseline in Body Weight, Baseline, Week 24 | Secondary: Percent Change from Baseline in Total Body Fat Mass by Dual-Energy X-Ray Absorptiometry (DXA), Baseline, Week 24, Week 48|Change from Baseline in Body Weight, Baseline, Week 24, Week 48|Percentage of Participants Achieving ≥5% Body Weight Reduction, Baseline, Week 24, Week 48|Percentage of Participants Achieving ≥10% Body Weight Reduction, Baseline, Week 24, Week 48|Percentage of Participants Achieving ≥15% Body Weight Reduction, Baseline, Week 24, Week 48|Change from Baseline in Waist Circumference, Baseline, Week 24, Week 48|Change from Baseline in Body Mass Index (BMI), Baseline, Week 24, Week 48|Change from Baseline in Waist-to-Height Ratio (WHtR), Baseline, Week 24, Week 48|Percent Change from Baseline in Visceral Adipose Tissue (VAT), Baseline, Week 24, Week 48|Percent Change from Baseline in Total Body Lean Mass by DXA, Baseline, Week 24, Week 48
|
| Locations: |
Pinnacle Research Group, LLC, Anniston, Alabama, 36207, United States|Central Research Associates, Birmingham, Alabama, 35205, United States|Diablo Clinical Research, Inc., Walnut Creek, California, 94598, United States|Clinical Neuroscience Solutions, Inc. dba CNS Healthcare, Jacksonville, Florida, 32256, United States|Altus Research, Lake Worth, Florida, 33461, United States|Suncoast Research Group, Miami, Florida, 33135, United States|East-West Medical Research Institute, Honolulu, Hawaii, 96814, United States|Great Lakes Clinical Trials - Ravenswood, Chicago, Illinois, 60640, United States|SKY Integrative Medical Center/SKYCRNG, Ridgeland, Mississippi, 39157, United States|Keystone Clinical Studies, Plymouth Meeting, Pennsylvania, 19462, United States|Eastside Research Associates, Redmond, Washington, 98052, United States|Rainier Clinical Research Center, Renton, Washington, 98057, United States
|
